Download PDF

Other users also viewed these articles

SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma Ying Liu; Taoying Chen; Li Tang; Daqing Cheng; Ming Xu; Jiaoxiang Wu; Bingyan Liu; Hao Cheng; Bo Han; Yu Zhang; Sheng Cheng;
10.1016/j.clinsp.2025.100796
Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases Paulo Herman; Gilton Marques Fonseca; Fabricio Ferreira Coelho; Jaime Arthur Pirola Kruger; Fabio Ferrari Makdissi; Vagner Birk Jeismann; Flair José Carrilho; Luiz Augusto Carneiro D'Albuquerque; Sergio Carlos Nahas;
Clinics. 2022;77C:
Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series Regiane Saraiva de Souza Melo Alencar; Claudia P. Oliveira; Aline Lopes Chagas; Leonardo Gomes da Fonseca; Claudia Maccali; Lisa Rodrigues da Cunha Saud; Mariana Pinheiro Xerfan; Jose Tadeu Stefano; Paulo Herman; Luiz Augusto Carneiro D'Albuquerque; Venâncio Avancini Ferreira Alves; Flair Jose Carrilho;
Clinics. 2022;77C: